MLMIC’s Q2 Statement Shows Continued Strength and Stability
MLMIC’s Q2 financials show continued strength and stability for New York’s leading medical liability insurer. Given recent press comparing us and our major competitor in New York, it is reassuring to know that, as New York’s leading medical liability insurer, MLMIC is sound and ready to serve its policyholders.
MLMIC’s second quarter financial statement indicates assets of $5.5 billion, liabilities of $3.7 billion and a policyholders’ surplus of $1.8 billion. Operating results through six months have been profitable, aided by realized investment gains.
The full financial statement for Q2 has been filed with the regulator, and a summary of key financial indicators is available here.
We want you to be among the first to know our latest good news: MLMIC has entered into a definitive agreement to be acquired by National Indemnity Company, a subsidiary of Berkshire Hathaway.
MLMIC will not raise rates for physician policyholders this year. In addition, it announces credits for the 20% dividend and expands claims-free discount program.
While MLMIC can’t speak to the coverage of our competitors, we can assure our policyholders that MLMIC’s level of protection remains unchanged. We continue to provide exceptional coverage, a strong risk management program and high quality legal counsel.